580 California St., Suite 400
San Francisco, CA, 94104
Key research themes
1. What are the microbiological and immunological mechanisms underlying vaginal irritation related to vulvovaginal candidiasis and associated dysbiosis?
This research theme investigates the complex microbiological dynamics and host immune responses particularly involved in vulvovaginal candidiasis (VVC), including the role of Candida species, vaginal microbiota dysbiosis, immune pathways such as neutrophil extracellular trap (NET) formation, and fungal virulence factors. Understanding these mechanisms is critical for developing targeted therapies and improving management of vaginal irritation stemming from infections and dysbiosis.
Key finding: This paper elucidates the pathophysiology of vulvovaginal candidiasis, highlighting that C. albicans causes most VVC cases by adhering to vaginal epithelial cells and forming mycelium that can penetrate up to 10 cell layers,... Read more
Key finding: This exploratory study revealed an increased presence of neutrophil extracellular traps (NETs) and NETotic cells in vaginal discharges from women with Candida albicans and Trichomonas vaginalis infections. Different NET... Read more
Key finding: This study identifies a significant association between vaginal douching (VD) and alterations in the vaginal mycobiota, showing that 67.4% of women with vulvovaginal candidiasis practiced VD. It reports that C. albicans... Read more
Key finding: Comprehensive review reveals that vulvovaginal candidiasis results from an overabundance and epithelial invasion of Candida, primarily C. albicans, which causes characteristic symptoms like pruritus and cottage-cheese... Read more
2. How can diagnostic accuracy for common causes of vaginal irritation improve clinical management and treatment outcomes?
Accurate and timely diagnosis of vaginal conditions causing irritation, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis, is essential to guide effective treatment and reduce unnecessary medication use. This theme encompasses the evaluation of diagnostic test performance, comparison of clinical versus molecular methods, and validation of patient self-collected samples to optimize diagnosis in both community and specialized settings.
Key finding: This multicenter study validates a molecular-based vaginal swab test demonstrating sensitivities over 90% and specificities above 85% for detecting bacterial vaginosis, candidiasis, and trichomoniasis compared to... Read more
Key finding: This study assesses diagnostic practices in community clinics and finds considerable discordance between clinical diagnoses and laboratory-based testing for BV, VVC, and TV. It highlights the limited sensitivity of... Read more
Key finding: The article stresses the fundamental role of simple bedside tests—vaginal pH measurement and microscopic examination of wet mounts—in diagnosing common vaginal infections causing irritation. It argues that despite their... Read more
Key finding: The cross-sectional study evaluates multiple diagnostic methods for BV and TV, including clinical criteria (Amsel), Nugent scoring, and molecular PCR. Nugent scoring remains the gold standard for BV diagnosis, while PCR... Read more
Key finding: Findings indicate that many women with vaginal irritation are misdiagnosed due to reliance on clinical findings alone; laboratory tests outperform clinical diagnosis in detecting BV, VVC, and TV. The study underscores the... Read more
3. What are effective management and treatment strategies for postmenopausal vaginal irritation associated with vulvovaginal atrophy and related mucosal changes?
This theme focuses on therapeutic approaches to vaginal irritation in postmenopausal women, particularly relating to vulvovaginal atrophy/genitourinary syndrome of menopause. It examines the efficacy and safety of low-dose vaginal estrogen treatments and nonhormonal moisturizers to relieve symptoms such as dryness, pain, and irritation, addressing the need for individualized, minimally systemic interventions to improve quality of life.
Key finding: This 12-week randomized trial demonstrated that low-dose vaginal estradiol tablets significantly reduced moderate-to-severe vulvovaginal symptoms compared to placebo, while vaginal moisturizer showed limited efficacy. The... Read more
Key finding: The phase 3 trial found that a very low-dose estradiol vaginal cream applied twice weekly significantly improved vaginal dryness, increased vaginal superficial cell percentages, and lowered vaginal pH compared with placebo,... Read more
Key finding: The work notes the high prevalence of VVC in postmenopausal women despite normal flora presence and acknowledges the complexity of managing symptoms related to vulvovaginal atrophy. It underscores the importance of tailored... Read more
Key finding: The paper proposes that noninfectious causes such as genital contact allergy must be considered in persistent vulvovaginitis and irritation unresponsive to standard treatments. It highlights that allergic reactions—often... Read more